🇺🇸 FDA
Pipeline program

ARC-520

Heparc-2001

Phase 2 small_molecule terminated

Quick answer

ARC-520 for Hepatitis B, Chronic is a Phase 2 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ARROWHEAD PHARMACEUTICALS, INC.
Indication
Hepatitis B, Chronic
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials